Four paying subscribers sue Anthropic, OpenAI, Google and SpaceXAI, alleging that a coordinated AI slowdown violates antitrust law

The legal core of the complaint is that it splits the word slowdown into two acts of very different character. Per Quartz, the lawsuit does not challenge a company individually choosing to slow its own AI development; that is a firm's own commercial judgement. What it contests is the act of coordinating that restraint with rivals. In the plaintiffs' words, antitrust law does not permit competitors to use the shortcut of substituting collective restraint for individual accountability. The Associated Press quotes the argument more plainly: it is clear that an agreement among the chief rivals in AI that their progress should be slower than competition would otherwise produce has an anticompetitive effect on consumers. Nick Rowley, the lead attorney for the plaintiffs, pushes the concern to its limit in a statement: AI will quickly spin out of human control and could kill us all if we allow AI safety and protocol to be controlled by private self-serving agreements between the world's most powerful for profit technology companies.

Two dates anchor the complaint. The first is September 12, 2026: Anthropic chief executive Dario Amodei published an essay that day urging industrywide cooperation on decelerating advancements in favour of safety measures, and the same day OpenAI chief executive Sam Altman, SpaceXAI chief executive Elon Musk and Google DeepMind co-founder and chair Demis Hassabis each publicly responded in agreement with his proposals. The lawsuit argues the coordination largely took place on that day. The second date is earlier: the complaint points to a July 2026 statement signed by high-ranking employees from several leading AI labs, which acknowledged intense competitive pressure not to unilaterally slow development and urged the government to back a worldwide push to decelerate automated AI development. The alleged coordination, in other words, is not framed as a single event but as a thread running from July into September.

Notably, Amodei's own essay addresses the antitrust problem head on. According to Quartz and the Associated Press, he proposed in it a three-step plan he called pacing the frontier, which included placing outside evaluators inside AI companies, reaching industry-wide agreement on shared safety benchmarks, and constraints on how fast capabilities can advance. He acknowledged potential antitrust challenges in the essay itself, writing that it would be helpful for the US government to mediate or at least enable these cross-lab discussions; the government would not need to participate, he wrote, but would need to issue a narrow waiver for certain kinds of safety conversations. Altman's response on social media was that OpenAI welcomes the idea of a federal framework that sets consistent safety requirements, but he added that we do not believe we need to wait for an anti-trust exemption or legislation to begin the work of providing this confidence. That exchange lays out the tension of the whole affair: one side is asking for a waiver, the other says none is needed.

Finally, the practical prospects for this route. Per Quartz, prospects for a government-backed framework appear limited: Donald Trump has dismissed calls for regulation, labelling efforts to limit the technology a conspiracy, and announced on Saturday that an AI task force is in the works along with plans to name an AI czar, offering no additional details. The signal from Congress is no friendlier: Senator Josh Hawley, Republican of Missouri, said in a recent Senate hearing that there is no world in which he would grant the largest technology companies an antitrust exemption to collaborate. The reporting adds that representatives for Anthropic, OpenAI, Google and SpaceXAI did not immediately respond to a request for comment Saturday. Put those four pieces together and one thing is clear: the courts are not the only venue here, and right now neither the legislative nor the executive branch is offering the exit the plaintiffs want, or the exemption the defendants might need.